paeds meds Flashcards
classification of paediatric age group
premature neonate: <37w
term neonate: 37-41w
neonate: 0-28d post natal
infant: 1m -1y
child : 1-12y
adolescent: 13-18yo
adult: 18yo >
absorption in paeds
children has a slower absorption by oral route and longer gastric emptying time
distribution in paeds
total body water increased in children
decrease in protein binding
larger volume of distribution in neonates and infants
metabolism and elimination in paeds
slow metabolism in newborns
reduced clearance rate and prolonged t1/2
renal excretion is reduced
to measure renal function
schwartz eqn: (k x cm)/ SCr in mg/dl
bedside schwartz: (0.413 x cm)/ SCr in mg/dl
mmol-> mg/dl: divide by 88.4
paracetamol
inhibits cox, no anti-inflammatory property
PO/PR: 10-15mg/kg/dose q4-6h max 75mg/kg or 4g whichever is lower
ibuprofen
inhibits central and peripheral cox
> 6m: PO 5-10mg/kg/dose q6-8h
max 40mg/kg/d or 400mg/single dose
> 12yo/>40kg: PO 200-400mg q6-8h
diclofenac
> 1yo: PO/PR 0.5-2mh/d in 2-3 divided doses max 150mg/d
chlorpheniramine
> 6m: 0.35mg/kg/d TDS dosing
diphenhydramine
used as anti-tussive
2-6yo: 6.25mg q6h (max 37.5mg/d)
6-12yo: 12.5mg q8h (max 75mg/d))
*max 6 doses for both
promethazine
> 2yo: 0.2-0.5mg/kg/dose BD-TDS
ceterizine
2-5yo: 2.5mg OD-BD
> 6yo: 5mg BD -10mg OD
desloratadine
1-2yo (only for urticaria): 1.25mg/d
2-11yo: 1.25mg/d
> 12yo: 5mg/d
fexofenadine
6m-2yo (only for chronic idiopathic urticaria): 15mg BD
2-11yo: 30mg BD
>12yo: 60mg BD
oxymetazoline
alpha adrenergic agonist that vasoconstrict the dilated blood vessels in nasal mucosa
<1yo: 0.01%
2-6yo: 0.025%
>6yo: 0.05%
SE: burning, stinging, dryness, headache, avoid for >5yo